- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Amrita Institute of Medical Sciences & Research Center
Total 2655 results
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasRecruiting
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasActive, not recruitingBreast Cancer FemaleUnited States
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedPrevention Harmful Effects | Compliance Behavior | Non-Small Cell Lung CarcinomaUnited States
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedMalignant Gliomas | Astrocytomas | OligodendrogliomasUnited States
-
University of WashingtonFred Hutchinson Cancer Center; National Institute of General Medical Sciences...CompletedAdverse Drug InteractionsUnited States
-
Postgraduate Institute of Medical Education and...Radiological Society of North AmericaRecruitingGallbladder CancerIndia
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEsophageal Cancer | Chemotherapy | Immunotherapy | Chemoradiotherapy | NimotuzumabChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEndometrial Carcinoma | Recurrent or Metastatic | TP53 MutationChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingEarly-stage Triple-negative Breast Cancer With BRCA1/2 MutationsChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingLipids | Young Breast Cancer Patient | Anti-tumour Drug Therapy
-
Cancer Institute and Hospital, Chinese Academy...RecruitingPancreatic Adenocarcinoma | Advanced Cancer | Drug Use | Capecitabine | Oxaliplatin | First-Line | Cadonilimab | Nanoliposomal IrinotecanChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingPancreas Cancer
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHepatocellular Carcinoma | Radiotherapy | Tislelizumab | Tumor ThrombosisChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Colorectal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck Squamous Cell CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck Squamous Cell CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Recurrent Colorectal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTargeted Therapy | HR+/HER2- Advanced Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingAdvanced Lung CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBreast Cancer | Chemotherapy EffectChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLimited Stage Small Cell Lung CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingPatients With Advanced Solid TumorsChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSarcoma,Soft Tissue | Trunk | Extremity | Intensity-modulated Radiotherapy | Major Wound Complications | Targetd TherapyChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Colorectal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingRefractory Lymphoma | DLBCL | MYD88 Gene Mutation | Relapse | CD79A Gene Mutation | CD79B Gene Mutation
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHepatocellular Carcinoma Resectable
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEsophageal Squamous Cell CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEsophageal Cancer | Chemoradiation | Surgery | Chemotherapy Effect | Immunotherapy | Targeted Therapy | Esophagogastric Juction CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-Small Cell Lung CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingAdvanced Hepatocellular Carcinoma | Radiotherapy | Sorafenib | ToripalimabChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingUntreated Advanced NSCLC Patients | FISH Identified ALK Fusion Positive or NegativeChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHER2-positive Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingConcurrent Chemoradiotherapy | Nasopharyngeal Squamous Cell Carcinoma | Stage II, III | Induction Chemotheray | Reduce Treatment IntensityChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHepatocellular CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingLocally Advanced Pancreatic CancerChina